Tag: Gilead Sciences

“WE NEED MORE” by Sharon Rondeau (May 1, 2020) — At approximately 4:00 p.m. on Friday, President Trump spoke from the Oval Office about Remdesivir as a promising treatment for coronavirus, introducing Gilead Sciences CEO Daniel O’Day to provide details about the drug’s use during the U.S. pandemic. On Wednesday, NIAID Director Dr. Anthony Fauci…